SCHEMBL24157645

SCHEMBL24157645

CCC(C(C)C)C(C)(C)c1cn(C(C)C)nn1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27249327 0.79 HTT (0.31) CTSS
SCHEMBL22810865 0.76 HMGCR (0.31) CTSS
SCHEMBL10129385 0.75 GABRA2 (0.37)
SCHEMBL20282388 0.73 IRAK4 (0.34) CTSS
SCHEMBL14417165 0.72 AR (0.42) CTSS
SCHEMBL20997233 0.72
SCHEMBL22021705 0.72
SCHEMBL15059775 0.72
SCHEMBL25009052 0.72 ACHE (0.35)
SCHEMBL18812115 0.70 DPP4 (0.32) CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544975-B1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND USE DANA FARBER CANCER INST INC (US) 2022-01-05 EP disclosed